Activity of silver nanoparticles on prokaryotic cells and Bothrops jararacussu snake venom

References

• Ames, B.N., Lee, F.D., and Durston, W.E., 1973. An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proceedings of the National Academy of Sciences of the United States of America, 70 (3), 782–786.
   PubMed Web of Science ®Google Scholar
• Ames, B.N., McCann, J., and Yamasaki, E., 1975. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutation Research, 31 (6), 347–364.
   PubMed Web of Science ®Google Scholar
• Araujo, R.T., et al., 2017. Can anti-bothropstoxin-I antibodies discriminate between Bothrops jararaca and Bothrops jararacussu venoms? Journal of Venomous Animals and Toxins Including Tropical Diseases, 23 (1), 12.
   PubMed Web of Science ®Google Scholar
• Bernstein, L., et al., 1982. An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutation Research, 97 (4), 267–281.
   PubMedGoogle Scholar
• Biswas, A., et al., 2012. Nanoparticle-conjugated animal venom-toxins and their possible therapeutic potential. Journal of Venom Research, 3, 15–21.
   PubMedGoogle Scholar
• Brasil. 2001. Manual de diagnóstico e tratamento de acidentes por animais peçonhentos. Brasília, MS. Available from: http://portal.saude.gov.br/portal/arquivos/pdf/manu_peconhentos.pdf [Accessed 24 January 2018].
   Google Scholar
• Bülbring, E., 1946. Observation on the isolated phrenic nerve diaphragm preparation of the rat. British Journal of Pharmacology and Chemotherapy, 1 (1), 38–61.
   PubMed Web of Science ®Google Scholar
• CONCAWE (Conservation of Clean Air and Water in Europe), 2012. Use of the modified Ames test as an indicator of the carcinogenicity of residual aromatic extracts. CONCAWE Report number 12/12, Brussels: CONCAWE, p. 30.
   Google Scholar
• Cramer, S., et al., 2014. The influence of silver nanoparticles on the blood-brain and the blood-cerebrospinal fluid barrier in vitro. Journal of Nanomedicine & Nanotechnology, 5, 225. doi:10.4172/2157-7439.1000225
   Google Scholar
• Farrapo, N.M., et al., 2011. Inhibition of Bothrops jararacussu venom activities by Plathymenia reticulata Benth extracts. Journal of Venom Research, 2, 52–58.
   PubMedGoogle Scholar
• Ferraz, M.C., et al., 2014. An isoflavone from Dipteryx alata Vogel is active against the in vitro neuromuscular paralysis of Bothrops jararacussu snake venom and bothropstoxin-I, and prevents venom-induced myonecrosis. Molecules, 19 (5), 5790–5805.
   PubMed Web of Science ®Google Scholar
• Fonseca, M.G., et al., 2009. Microbiota of Brazilian captive snakes. Journal of Venomous Animals and Toxins Including Tropical Diseases, 15 (1), 54–60.
   Web of Science ®Google Scholar
• Gallacci, M., and Cavalcante, W.L., 2010. Understanding the in vitro neuromuscular activity of snake venom Lys49 phospholipase A2 homologues. Toxicon: Official Journal of the International Society on Toxicology, 55 (1), 1–11.
   Google Scholar
• Guo, X., et al., 2016. Size- and coating-dependent cytotoxicity and genotoxicity of silver nanoparticles evaluated using in vitro standard assays. Nanotoxicology, 10 (9), 1373–1384.
   PubMed Web of Science ®Google Scholar
• Jho, Y.S., et al., 2011. Identification of bacteria from the oral cavity and cloaca of snakes imported from Vietnam. Laboratory Animal Research, 27 (3), 213–217.
   PubMedGoogle Scholar
• Jorge, M.T. and Ribeiro, L.A., 1997. Infections in the bite site after envenoming by snakes of the Bothrops genus. Journal of Venomous Animals and Toxins, 3 (2), 264–272.
   Google Scholar
• Jorge, M.T. and Ribeiro, L.A., 1990. Acidentes por serpentes peçonhentas do Brasil. Revista da Associação Médica Brasileira, 36, 66–77.
   Google Scholar
• Maron, D.M. and Ames, B.N., 1983. Revised methods for the salmonella mutagenicity test. Mutation Research, 113 (3–4), 173–215.
   PubMed Web of Science ®Google Scholar
• Matthews, L., et al., 2010. Applications of nanomedicine in antibacterial medical therapeutics and diagnostics. The Open Tropical Medicine Journal, 3 (1), 1–9.
   Google Scholar
• McGonigal, R., et al., 2010. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain: A Journal of Neurology, 133 (7), 1944–1960.
   PubMedGoogle Scholar
• Milani, J.R., et al., 1997. Snake bites by the jararacuçu (Bothrops jararacussu): clinicopathological studies of 29 proven cases in São Paulo State. QJM: Monthly Journal of the Association of Physicians, 90 (5), 323–334.
   PubMedGoogle Scholar
• Mortelmans, K. and Zeiger, E., 2000. The Ames Salmonella/microsome mutagenicity assay. Mutation Research, 455 (1–2), 29–60.
   PubMed Web of Science ®Google Scholar
• Myrzakhanova, M., et al., 2013. Effects of nanosilver exposure on cholinesterase activities, CD41, and CDF/LIF-like expression in zebraFish (Danio rerio) larvae. BioMed Research International, 2013, 1–12. http://dx.doi.org/10.1155/2013/205183
   Google Scholar
• Nel, A.E., et al., 2009. Understanding biophysicochemical interactions at the nano–bio interface. Nature Materials, 8 (7), 543–557.
   PubMed Web of Science ®Google Scholar
• Oshima-Franco, Y., et al., 2004. The presynaptic activity of bothropstoxin-I, a myotoxin from Bothrops jararacussu snake venom. Pharmacology and Toxicology, 95 (4), 175–182.
   Google Scholar
• Pal, S.K., et al., 2002. Snake venom as therapeutic agents: from toxin to drug development. Indian Journal of Experimental Biology, 40 (12), 1353–1358.
   PubMedGoogle Scholar
• Panyala, N.R., Pena-Mendez, E.M., and Havel, J., 2008. Silver or silver nanoparticles: a hazardous threat to the environment and human health? Journal of Applied Biomedicine, 6, 117–129.
   Web of Science ®Google Scholar
• Patlolla, A.K., Hackett, D., and Tchounwou, P.B., 2015. Silver nanoparticle-induced oxidative stress-dependent toxicity in Sprague-Dawley rats. Molecular and Cellular Biochemistry, 399 (1–2), 257–268.
   PubMed Web of Science ®Google Scholar
• Resende, F.A., et al., 2012. Mutagenicity of flavonoids assayed by bacterial reverse mutation (Ames) test. Molecules (Basel, Switzerland), 17 (5), 5255–5268.
   PubMed Web of Science ®Google Scholar
• Santos, C.A., et al., 2016. Production, stabilization and characterization of silver nanoparticles coated with bioactive polymers pluronic F68, PVP and PVA. IET Nanobiotechnology, 11, 552–556.
   Web of Science ®Google Scholar
• Santos, C.A., et al., 2014. Silver nanoparticles: therapeutical uses, toxicity and safety issues. The Journal of Pharmaceutical Sciences, 103 (7), 1931–1944.
   PubMed Web of Science ®Google Scholar
• Susuki, K., 2013. Node of Ranvier disruption as a cause of neurological diseases. ASN Neuro, 5 (3), 209–219.
   Web of Science ®Google Scholar
• Xu, L., et al., 2015. Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood–brain barrier primary triple coculture model. International Journal of Nanomedicine, 10, 6105–6119.
   PubMed Web of Science ®Google Scholar
• Yoshida, E.H., et al., 2016. Evaluation of betulin mutagenicity by Salmonella/Microsome test. Advanced Pharmaceutical Bulletin, 6 (3), 443–447.
   PubMed Web of Science ®Google Scholar